Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

An outbreak of African swine fever was detected at Rusagro's pork complex

11/13/23 RAGR

Rosbank reported for 9 months of 2023 by IFRS

11/13/23 ROSB

Lukoil agreed with China's Seven on cooperation on the MCC project in Budennovsk

11/13/23 LKOH

JSCB Primorye reported for 9 months of 2023 by RAS

11/13/23 PRMB

NovaBev Group reported for 9 months of 2023 by RAS

11/13/23 BELU

Sitronics Group has successfully tested an autonomous river vessel

11/13/23 AFKS

MD Medical opens a multidisciplinary hospital Michurinsky

11/13/23 MDMG

Board of Directors of NovaBev Group recommended that dividends be paid for 9 months 2023

11/13/23 BELU

RusAgro reported for 9 months of 2023

11/13/23 RAGR

Moscow Exchange's profit in Q3 increased by 64%

11/13/23 MOEX